Treatment

AGA2115 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
This study is testing a new medicine, AGA2115, for adults with a bone condition called osteogenesis imperfecta (OI) of types I, III, or IV. It aims to see if the medicine is safe and if it helps strengthen bones compared to a dummy treatment.
For: Osteogenesis Imperfecta (OI)
United States · Argentina · Australia